Table 3

Risk of all-cause mortality, ischaemic and haemorrhagic stroke according to the statin treatment after diagnosis of MMD

OutcomeHaemorrhagic strokeIschaemic strokeDeath
No of events458173237
Adjusted HR (95% CI)* for statin treatment, p value0.74 (0.58 to 0.95), 0.0180.75 (0.52 to 1.08), 0.1240.47 (0.33 to 0.67), <0.001
  • Data were obtained from multivariable time-dependent Cox proportional hazard regression models for each outcome. When a competing event occurred, the subject was censored at that time.

  • *Adjusted for the covariates listed in table 2.

  • MMD, moyamoya disease.